020 512 9111
  1. Home
  2. Information about cancer
  3. Quality indicators cancer types
  4. Quality of treatment for melanoma

Melanoma

Read more about the patient satisfaction rates, our specialists' expertise, innovations, and wait times for melanoma treatment.

John Haanen in gesprek (melanoom, nierkanker)
We have a lot of experience and expertise in the treatment of melanomas and offer patients the option to participate in the latest trials.
Prof. dr. John Haanen Internist

Patient satisfaction

Patient satisfaction rates are the opinions of our patients on the care and services they received at the Netherlands Cancer Institute. Our patients named expertise, personal care, information, trust, and the possibility to be involved as important aspects in their ratings of the Netherlands Cancer Institute.

8.4

Patiëntenwaardering

Patiënten met melanoom beoordelen het Antoni van Leeuwenhoek in 2022 met de volgende rapportcijfers.

Deel uw eigen ervaring
  • 8.8
    Deskundigheid
  • 8.5
    Luisteren
  • 8.4
    Uitleg
  • 8.2
    Wensen bij keuze behandeling
  • 8.3
    Samen beslissen
Nollen
"I felt safe knowing that everybody has a lot of experience treating cancer patients, and understand what patients are going through."
Astrid Nollen Patient

Expertise

Expertise is the experience and skill of our specialists, specific to this cancer type. We measure their expertise by keeping records of the numbers of patients treated, the numbers of patients requesting a second opinion, and the types of treatments being delivered.

The following data is based on the year 2015

 

  • 2976

    patiënten met melanoom

Further division by treatment type

The expertise of our team of specialists is based on the three main treatments: the number of patients receiving surgery, radiation, and/or treatment with cancer drugs. We will give you further insights into our experience per treatment.

Drug treatments (most common)

  • 370

    Immuuntherapie

  • 184

    doelgerichte therapie

Many patients at the Netherlands Cancer Institute participate in a clinical trial looking into drug treatments, such as immunotherapy. These patients have not been included in the overview. 

Surgical treatments (most common)

  • 105

    klierdissecties

  • 165

    Verwijderen poortwachtersklier

  • 40

    oncolytische virale immuuntherapie

  • 15

    perfusies

Radiation treatments (most common)

  • 61

    radiotherapeutische behandelingen
Aleaxander van Akkooi in gesprek (2) (melanoom)
It is quite amazing how we can combine the latest targeted therapies, immune therapies, and surgery for melanoma.
Dr. Alexander van Akkooi Surgeon

Wait times

Our wait times are currently longer than we would like for certain treatments. Displayed below are the expected wait times.

Our physicians closely monitor whether the wait time is acceptable for you based on your situation and physical shape. The wait times may differ between patients if the situation requires it.

6
days

First appointment

Wait time until the first appointment

80% of our patients are seen within one week.

Establishing a treatment plan

Between your first visit to the clinic and the first diagnostics, there may be a period for additional tests, and for the specialists involved in the treatment to discuss and establish the treatment plan with the patient.
Start of treatment

Start of the treatment

Wait times until the start of the treatment

Our patients will start treatment within the following number of days: 

1. Surgical treatment:                35-49 days

2. Treatment with medication       <21 days
This website uses cookies

We use cookies on our website to improve the user experience.